Systemic Corticosteroid Pulse Therapy (e.g., Dexamethasone)

Treatment for Vitiligo

Typical Dosage: Dexamethasone 2.5-5 mg on 2 consecutive days per week

Effectiveness
65%
Safety Score
35%
Clinical Trials
30
Participants
2K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
35
DangerousModerateSafe
Treatment Details
Dosage Range
Dexamethasone 2.5-5 mg on 2 consecutive days per week
Time to Effect
1-2 months
Treatment Duration
3-6 months
Evidence Quality
MODERATE
Number Needed to Treat (NNT)
3(Treat 3 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
8(Treat 8 patients to see 1 additional serious adverse event)
Confidence Score
75%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$100
Monitoring:$400
Side Effect Mgmt:$200
Total Annual:$700
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$8,750/QALY
QALYs Gained
0.08
Outcome-Based Costs
Cost per Responder
$1,166.67
Cost per Remission
$14,000
Systemic Corticosteroid Pulse Therapy (e.g., Dexamethasone) Outcomes

for Vitiligo

Efficacy Outcomes
Overall Effectiveness
+65%
Response Rate
+60%
Remission Rate
+5%
Common Side Effects
Weight gain
+50%
Insomnia
+40%
Mood changes
+30%
Hypertension
+20%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov